Prof Interventional cardiology Oxford University
Oxford University
Appointed Consultant Cardiologist at the John Radcliffe in Oxford in 1999. At the forefront of the initiation of day case coronary intervention and prominent in the early development of drug eluting stents particularly the Taxus series of trials. One of the top 5 recruiters in trials of stents vs surgery including Syntax and Excel. Academic interests in left main disease, intravascular imaging and myocardial injury during revascularisation. Live case operator for TCT and PCR and former President of BCIS and steering group member of EBC
Saturday, February 25, 2023
4:00 PM – 5:00 PM ET
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)
Saturday, February 25, 2023
4:00 PM – 4:04 PM ET
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)
Saturday, February 25, 2023
4:55 PM – 5:00 PM ET
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)
Sunday, February 26, 2023
10:00 AM – 11:15 AM ET
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)
Sunday, February 26, 2023
10:56 AM – 11:15 AM ET
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)